Achucarro Basque Center for Neuroscience

Wren Builds Out Scientific Advisory Board for Neurodegenerative Diseases

Retrieved on: 
Wednesday, January 4, 2023
Dementia, Medical laboratory, University of Kansas Medical Center, Essential tremor, Neurodegeneration, MIND, University of Nevada, Reno, MTR, School, Achucarro Basque Center for Neuroscience, Drug discovery, Lewy body, Parkinson's disease, Drug development, Neuroinflammation, Science Publishing Group, University, Perelman School of Medicine at the University of Pennsylvania, Doctor of Science, Pathology, Ikerbasque, Therapy, MSA, ALS, Doctor of Philosophy, SAB, Research, Multiple system atrophy, Coronavirus Scientific Advisory Board (Turkey), Movement disorders, Pharmaceutical industry, Medical device, Alzheimer's disease, Neuroscience, Neurology, Wren, MD

BOSTON, Jan. 4, 2023 /PRNewswire/ -- Wren Therapeutics announced today a number of new members to its Scientific Advisory Board.

Key Points: 
  • BOSTON, Jan. 4, 2023 /PRNewswire/ -- Wren Therapeutics announced today a number of new members to its Scientific Advisory Board.
  • "Each of our SAB members brings unrivaled scientific expertise across key areas of neurodegenerative disease biology, preclinical development, and clinical testing that will be invaluable as we advance our first-in-class small-molecule drugs for Parkinson's disease, Alzheimer's disease, and ALS into clinical trials."
  • He has been recognized for this research and leadership contributions in the field of Alzheimer's disease through numerous awards.
  • Her laboratory specializes in the identification and treatment of disease targets in neurodegenerative conditions through translational modeling.

Russell Public Communications Marks 20th Anniversary, Renews Its College Scholarship Program

Retrieved on: 
Thursday, January 13, 2022
Digital Pathology Association, National Comedy Center, Sandra, Research, Sahuaro High School, Quidel Corporation, Man, LinkedIn, Zee Entertainment Enterprises, Series, Public Relations Society of America, PR, Naturopathic Physicians Licensing Examinations, Public relations, Human, Center, Protandim, Facebook, National Coalition for Syrian Revolutionary and Opposition Forces, Achucarro Basque Center for Neuroscience, Association, Company, Arizona Historical Society, Alzheimer's disease, Politics, Woman, Medicine, HomeServices of America

TUCSON, Ariz., Jan. 13, 2022 /PRNewswire/ -- Russell Public Communications , an award-winning public relations and public affairs firm based in Tucson, marked its 20th anniversary this week and renewed its pledge to the Sahuaro Cougar Foundation to support college scholarships for graduating Sahuaro High School students.

Key Points: 
  • TUCSON, Ariz., Jan. 13, 2022 /PRNewswire/ -- Russell Public Communications , an award-winning public relations and public affairs firm based in Tucson, marked its 20th anniversary this week and renewed its pledge to the Sahuaro Cougar Foundation to support college scholarships for graduating Sahuaro High School students.
  • The firm launched the Russell Public Scholarship in 2012 and has since awarded $10,000 to college-bound Cougars.
  • Company Founder/CEO Matt Russell, a 1985 graduate of Sahuaro High School, noted the importance of giving back and the central role that plays in the firm's purpose.
  • A three-time recipient of the Public Relations Society of America-Southern Arizona Chapter's "Best in Show Impact Award" for PR campaign of the year, Russell Public Communications has represented a wide range of clients from its offices in Tucson and Washington, D.C.

PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development

Retrieved on: 
Tuesday, December 14, 2021
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Mental Health, Clinical Trials, Aurora, Investigational New Drug, ISS, Library, Advanced Space Vision System, Narcolepsy, ALS, Master of Science, Bipolar disorder, Algorithm, Sunovion, Intelligence, Muscular dystrophy, CMU, PTSD, CNS, Lists of diseases, Creativity, Industry, Biomarker, Uber, Time, DARPA, AI, Probability, Carnegie Mellon University, Drug discovery, Schizophrenia, Research, Autism, Robotics, Patient, Epilepsy, Cosmic Vision, Knowledge, Microdialysis, Electrophysiology, Molecular biology, Drug development, NASA, Psychology, Neurodegeneration, SRI International, EEG, Neuropsychiatry, Partnership, Achucarro Basque Center for Neuroscience, Depression, CRO, Translational neuroscience, Pharmaceutical industry, Medical device, Engineering, Shuttle

PsychoGenics Inc. announced the appointment of Stephen Morairty, Ph.D., as Vice President of Translational Neuroscience and Jean-Sebastien Valois, MSc, as Vice President of Engineering and AI Development.

Key Points: 
  • PsychoGenics Inc. announced the appointment of Stephen Morairty, Ph.D., as Vice President of Translational Neuroscience and Jean-Sebastien Valois, MSc, as Vice President of Engineering and AI Development.
  • Dr. Morairty brings over 30 years of research and drug development experience focusing on translational neuroscience and EEG biomarkers.
  • For the last 22 years he was at SRI International, most recently as Senior Director, leading collaborative efforts with industry on preclinical drug development through their Center for Neuroscience.
  • We are pleased to welcome Dr. Morairty to lead our expanding translational neuroscience team, said Dr. Emer Leahy, President and CEO of PsychoGenics.